Smith & Howard Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Smith & Howard Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-2,315	Closed	-$124K	–	173
2013 Q4	$124K	Sell	2,315 -312	-12%	-$15.6K	0.07%	71
2013 Q3	$121K	Hold	2,627	–	–	0.07%	50
2013 Q2	$111K	Buy	+2,627	New	+$109K	0.07%	54

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

PFG

Pacific Financial Group Bellevue, Washington $209M AUM 22.2% 1-Year Est. Return

Smith & Howard Wealth Management's PJP Position: Q1 2014 in Review

Smith & Howard Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2014, closing a stake of 2,315 shares — an estimated $124K sold.

Smith & Howard Wealth Management first reported a position in PJP in Q2 2013 and held it in 3 quarters. The position peaked at $124K in Q4 2013. 85 funds tracked by Wall St. Rank hold PJP as of Q1 2014.

Smith & Howard Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2014 after selling out during the quarter.
Smith & Howard Wealth Management sold 2,315 Invesco Pharmaceuticals ETF shares in Q1 2014, an estimated $124K.
Smith & Howard Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 3 quarters.
Smith & Howard Wealth Management's Invesco Pharmaceuticals ETF position peaked at $124K in Q4 2013.
85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2014.

Based on Smith & Howard Wealth Management's 13F filing for Q1 2014, filed 15 May 2014.